Transforming potential of the herpesvirus oncoprotein MEQ: Morphological transformation, serum-independent growth, and inhibition of apoptosis

Journal of Virology

Volumn 72, Issue 1, 1998, Pages 388-395

  Liu, Juinn Lin ^a,c   Ye, Ying ^b   Lee, Lucy F ^c   Kung, Hsing Jien ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c U S DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; CYCLOHEXIMIDE; ONCOPROTEIN; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; AVIAN LYMPHOMATOSIS HERPETOVIRUS; CELL DAMAGE; GENE EXPRESSION REGULATION; HERPES VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; ULTRAVIOLET IRRADIATION; VIRUS CELL TRANSFORMATION;

EID: 0031964527     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.1.388-395.1998     Document Type: Article

References (55)

1. Akiyama, Y., and S. Kato. 1974. Two cell lines from lymphomas of Marek's disease. Biken J. 17:105-116.
2. Angel, P., and M. Karin. 1991. The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim. Biophys. Acta 1072:129-157.
3. Bertin, J., R. C. Armstrong, S. Ottilie, D. A. Martin, Y. Wang, S. Banks, G.-H. Wang, T. G. Senkenvich, E. S. Alnemri, B. Moss, M. J. Lenardo, K. J. Tomaselli, and J. I. Cohen. 1997. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR-induced apoptosis. Proc. Natl. Acad. Sci. USA 94:1172-1176.
4. Bishop, J. M. 1991. Molecular themes in oncogenesis. Cell 64:235-248.
5. Brunovskis, P. 1997. Personal communication.
6. Calnek, B. W., W. R. Shek, and K. A. Schat. 1981. Spontaneous and induced herpesvirus genome expression in Marck's disease tumor cell lines. Infect. Immun. 34:483-491.
7. Calnek, B. W. 1985. Marek's disease - a model for herpesvirus oncology. Crit. Rev. Microbiol. 12:293-320.
8. Cheng, E. H., J. Nickolas, D. S. Bellows, G. S. Hayward, H. G. Guo, M. S. Reitz, and J. M. Hardwick. 1997. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc. Natl. Acad. Sci. USA 94:690-694.
9. Chinnaiyan, A. M., K. O'Rourke, B. R. Lane, and V. M. Dixit. 1997. Interactions of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science 275:1122-1126.
10. Cohen, J. I., F. Wang, J. Mannick, and E. Kieff. 1989. Epstein-Barr virus nuclear protein 2 is a key determinant of B lymphocyte transformation. Proc. Natl. Acad. Sci. USA 86:9558-9562.
11. Curran, T., and P. K. Vogt. 1992. Dangerous liaisons: Fos and Jun, oncogenic transcription factors, p. 797-836. In S. L. McNight and K. Yamamota (ed.), Transcription regulation. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
12. Fries, K. L., W. E. Miller, and N. Raab-Traub. 1996. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J. Virol. 70:8653-8659.
13. Hale, A. J., C. A. Smith, L. C. Sutherland, V. E. A. Stoneman, V. L. Longthorne, A. C. Culhane, and G. T. Williams. 1996. Apoptosis: molecular regulation of cell death. Eur. J. Biochem. 236:1-26.
14. Hammerschmidt, W., and B. Sugden. 1989. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature (London) 340:393-397.
15. Hannun, Y. A., and L. M. Obeid. 1995. Ceramide: an intracellular signal for apoptosis. Trends Biochem. Sci. 20:73-77.
16. Henderson, S., M. Rowe, C. Gregory, C. D. Croom, F. Wang, R. Longnecker, E. Kieff, and A. Rickinson. 1991. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-1115.
17. Henderson, S., D. Huen, M. Rowe, C. Dawson, G. Johnson, and A. Rickinson. 1993. Epstein-Barr virus-encoded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA 90:8479-8483.
18. Hu, S., C. Vincenz, M. Buller, and V. M. Dixit. 1997. A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis. J. Biol. Chem. 272: 9621-9624.
19. Jones, D., L. Lee, J.-L. Liu, H.-J. Rung, and J. K. Tillotson. 1992. Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. Proc. Natl. Acad. Sci. USA 89:4042-4046.
20. Kato, S., and K. Hirai. 1985. Marek's disease virus. Adv. Virus Res. 30:225-277.
21. Kaye, K. M., K. M. Izumi, and E. Kieff. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 90:9150-9154.
22. Kluck, R. M., E. Bossy-Wetzel, D. R. Green, and D. D. Newmeyer. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136.
23. Kung, H.-J., and J.-L. Liu. 1997. Retroviral oncogenesis, p. 235-266. In N. Nathanson et al. (ed.), Viral pathogenesis. Lippincott-Raven Publishers, Philadelphia, Pa.
24. Kung, H.-J., A. Tanaka, and M. Nonoyama. 1995. Two gene families of Marek's disease virus with a potential role in tumor induction in chicken. Int. J. Oncol. 6:997-1002.
25. Leopardi, R., and B. Roizman. 1996. The herpes simplex virus major regulatory protein ICP4 blocks apoptosis induced by the virus or by hyperthermia. Proc. Natl. Acad. Sci. USA 93:9538-9587.
26. Li, D. Unpublished results.
27. Liu, J.-L., L. F. Lee, Y. Ye, Z. Qian, and H.-J. Kung. 1997. Nucleolar and nuclear localization properties of a herpesvirus bZIP oncoprotein, MEQ. J. Virol. 71:3188-3196.
28. Mannick, J. B., J. I. Cohen, M. Birkenbach, A. Marchini, and E. Kief. 1991. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J. Virol. 65:6826-6837.
29. Miyashita, T., S. Krajewski, M. Kraikjeski, H. G. Wang, H. K. Lin, D. A. Liebermann, B. Hoffman, and J. C. Reed. 1994. Tumor-suppressor p53 is a regulator of bcl-2 and bax gene-expression in vitro and in vivo. Oncogene 9:1799-1805.
30. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer high titre retroviral vectors with multiple drug selection markers and a complementary helper packaging cell line. Nucleic Acids Res. 18:3587-3596.
31. Nazerian, K., E. A. Stephens, J. M. Sharma, L. F. Lee, M. Gailitis, and R. L. Witter. 1977. A nonproducer T lymphoblastoid cell line from Marek's disease transplantable tumor (JMV). Avian Dis. 21:69-76.
32. Nazerian, K., W. Payne, L. F. Lee, and R. L. Witter. 1978. Marek's disease virus (MDV) transformed lymphoblastoid cell line in a syngeneic system, abstr. S373, p. 274. In Abstracts of the 78th Annual Meeting of the American Society for Microbiology 1978. American Society for Microbiology, Washington, D.C.
33. Nazerian, K., R. L. Witter, L. B. Crittenden, M. R. Noori-Dalloii, and H.-J. Kung. 1982. An IgM-producing B lymphoblastoid cell line established from lymphomas induced by a non-defective reticuloendotheliosis virus. J. Gen. Virol. 58:351-360.
34. Nazerian, K., A. K. Elmubarak, and J. M. Sharama. 1982. Establishment of B-lymphoblastoid cell lines from Marek's disease virus-induced tumors in turkeys. Int. J. Cancer 29:63-68.
35. Okazaki, W., R. L. Witter, C. Romero, K. Nazerian, J. M. Sharama, A. Fadly, and D. Ewert. 1980. Induction of lymphoid leukosis transplantable tumors and the establishment of lymphoblastoid cell lines. Avian Pathol. 9:311-329.
36. Oltvai, Z. N., C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619.
37. 2, and BamHI-L fragments of the MDV genome form lymphoblastoid cells transformed and persistently infected with MDV. Virology 213:590-599.
38. Powell, P. C. 1985. Marek's disease virus in the chicken. Adv. Viral Oncol. 5:103-127.
39. Qian, Z., P. Brunovskis, F. Rauscher III, L. Lee, and H.-J. Kung. 1995. Transactivation activity of Meq, a Marek's disease herpesvirus bZIP protein persistently expressed in latently infected transformed T cells. J. Virol. 69: 4037-4044.
40. Qian, Z., P. Brunovskis, L. Lee, P. K. Vogt, and H.-J. Kung. 1996. Novel DNA binding specificities of a putative herpesvirus bZIP oncoprotein. J. Virol. 70:7161-7170.
41. Rowe, M., M. Peng-Pilon, D. S. Huen, R. Hardy, D. Groom-Carter, E. Lundgren, and A. B. Rickinson. 1994. Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-κB activation and to induction of cell surface markers. J. Virol. 68:5602-5612.
42. Schal, K. A., W. D. Pratt, R. Morgan, D. Weinstock, and B. W. Calnek. 1992. Stable transfection of reticuloendotheliosis virus-transformed lymphoblastoid cell lines. Avian Dis. 36:432-439.
43. Smith, C. A. 1995. A novel viral homologue of Bcl-2 and Ced-9. Trends Cell Biol. 5:344.
44. Spector, M. S., S. Desnoyers, D. J. Hoeppner, and M. O. Hengartner. 1997. Interaction between the C. elcgans cell-death regulators CED-9 and CED-4. Nature (London) 385:653-656.
45. Szekely, L., G. Selivanova, K. P. Magnusson, G. Klein, and K. G. Wiman. 1993. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc. Natl. Acad. Sci. USA 90:5455-5459.
46. Teodoro, J. G., and P. E. Branton. 1997. Regulation of apoptosis by viral gene products. J. Virol. 71:1739-1746.
47. Tillotson, J. K., H.-J. Kung, and L. F. Lee. 1988. Accumulation of viral transcripts coding for a DNA binding protein in Marek's disease tumor cells, p. 128-134. In The 3rd International Symposium on Marek's Disease. Japanese Association on Marek's Disease, Osaka, Japan.
48. Tomkinson, B., E. Robertson, and E. Kieff. 1993. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol. 67:2014-2025.
49. Vaux, D. L., and A. Strasser. 1996. The molecular biology of apoptosis. Proc. Natl. Acacl. Sci. USA 93:2239-2244.
50. Wang, D., D. Liebowitz, and E. Kieff. 1985. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840.
51. Wu D., H. D. Wallen, and G. Nunez. 1997. Interaction and regulation of subcellular localization of CED-4 by CED-9. Science 275:1126-1129.
52. Xie, Q., A. S. Anderson, and R. W. Morgan. 1996. Marek's disease virus (MDV) ICP4, pp38, and meq genes are involved in the maintenance of transformation of MDCC-MSB1 MDV-transformed lymphoblastoid cells. J. Virol. 70:1125-1131.
53. Yang, J., X. Liu, K. Bhalla, C. N. Kim, A. M. Ibrado, J. Cai, T.-I. Peng, D. P. Jones, and X. Wang. 1997. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129-1132.
54. Zhang, Q., D. Gutsch, and S. Kenney. 1994. Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Mol. Cell. Biol. 14:1929-1938.
55. Zhu, H., Y. Shen, and T. Shenk. 1995. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 69:7960-7970.